Financial statements Establo Pharma
Balance sheet data of ESTABLO PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 820 095,15 | 1 718 406,70 | 1 902 072,45 | 2 745 539,49 | 4 239 544,17 | 3 064 452,24 |
| A. Fixed assets | 99 179,60 | 61 600,97 | 45 928,91 | 54 950,23 | 47 463,92 | 42 715,39 |
| B. Current assets | 1 720 915,55 | 1 656 805,73 | 1 856 143,54 | 2 690 589,26 | 4 192 080,25 | 3 021 934,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 820 095,15 | 1 718 406,70 | 1 902 072,45 | 2 745 539,49 | 4 239 544,17 | 3 064 452,24 |
| A. Equity | 272 975,59 | 85 156,32 | 569 015,00 | 1 079 619,42 | 1 365 740,43 | 1 783 523,86 |
| B. Liabilities and provisions for liabilities | 1 547 119,56 | 1 633 250,38 | 1 333 057,45 | 1 665 920,07 | 2 873 803,74 | 1 280 928,38 |
| I. Long-term liabilities | 362 154,30 | 228 927,89 | 205 427,89 | 389 660,95 | 0,00 | 0,00 |
| II. Short-term liabilities | 1 183 929,72 | 1 404 322,49 | 1 127 629,56 | 1 176 977,57 | 2 672 437,68 | 784 367,92 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.